Large-scale testing (Phase 3)Active Not RecruitingNCT02962414
What this trial is testing
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
Who this might be right for
Tuberous Sclerosis Complex
Novartis Pharmaceuticals 206